Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
MJ Doenhoff, D Cioli, J Utzinger - Current opinion in infectious …, 2008 - journals.lww.com
Use of PZQ will increase in the foreseeable future, whether given alone or coadministered
with other anthelminthics in integrated control programmes. PZQ resistance remains a threat …
with other anthelminthics in integrated control programmes. PZQ resistance remains a threat …
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
MJ Doenhoff, D Cioli, J Utzinger - Current Opinion in Infectious …, 2008 - journals.lww.com
Use of PZQ will increase in the foreseeable future, whether given alone or coadministered
with other anthelminthics in integrated control programmes. PZQ resistance remains a threat …
with other anthelminthics in integrated control programmes. PZQ resistance remains a threat …
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
MJ Doenhoff, D Cioli, J Utzinger - Current Opinion in Infectious …, 2008 - europepmc.org
Use of PZQ will increase in the foreseeable future, whether given alone or coadministered
with other anthelminthics in integrated control programmes. PZQ resistance remains a threat …
with other anthelminthics in integrated control programmes. PZQ resistance remains a threat …
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
MJ Doenhoff, D Cioli, J Utzinger - Current opinion in …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose of review Praziquantel (PZQ) is the only drug being used to treat human
schistosomiasis on a large scale. This review focuses on current knowledge about the …
schistosomiasis on a large scale. This review focuses on current knowledge about the …
[PDF][PDF] Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
MJ Doenhoff, D Cioli, J Utzinger - Current Opinion in Infectious …, 2008 - academia.edu
The large majority of schistosome infections, and most of the severest disease caused by
schistosomes are now concentrated in relatively resource-poor countries of sub-Saharan …
schistosomes are now concentrated in relatively resource-poor countries of sub-Saharan …
[引用][C] Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
MJ Doenhoff, D Cioli, J Utzinger - Current Opinion in Infectious Diseases, 2008 - cir.nii.ac.jp
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁[サイニィ] 詳細へ移動 検索フォ恁 …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁[サイニィ] 詳細へ移動 検索フォ恁 …
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
MJ Doenhoff, D Cioli, J Utzinger - 2008 - cabidigitallibrary.org
Purpose of review: Praziquantel (PZQ) is the only drug being used to treat human
schistosomiasis on a large scale. This review focuses on current knowledge about the …
schistosomiasis on a large scale. This review focuses on current knowledge about the …